These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32767325)
1. ECT2 promotes proliferation and metastasis of esophageal squamous cell carcinoma via the RhoA-ERK signaling pathway. Sun BY; Wei QQ; Liu CX; Zhang L; Luo G; Li T; Lü MH Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7991-8000. PubMed ID: 32767325 [TBL] [Abstract][Full Text] [Related]
2. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278 [TBL] [Abstract][Full Text] [Related]
3. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion]. Xu H; Meng XR; Zhou Y; Wang F Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):105-113. PubMed ID: 32135643 [No Abstract] [Full Text] [Related]
4. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma. Zhang J; Liu S; Zhang D; Ma Z; Sun L J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888 [TBL] [Abstract][Full Text] [Related]
5. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways]. Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051 [No Abstract] [Full Text] [Related]
6. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression]. Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136 [No Abstract] [Full Text] [Related]
7. WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells. Chai DM; Qin YZ; Wu SW; Ma L; Tan YY; Yong X; Wang XL; Wang ZP; Tao YS J Exp Clin Cancer Res; 2019 Feb; 38(1):102. PubMed ID: 30808397 [TBL] [Abstract][Full Text] [Related]
8. Sporoderm-Removed Liu G; Zeng T Integr Cancer Ther; 2021; 20():15347354211062157. PubMed ID: 34841952 [TBL] [Abstract][Full Text] [Related]
9. LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway. Fang Y; Zhang S; Yin J; Shen YX; Wang H; Chen XS; Tang H Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3694-3700. PubMed ID: 32329845 [TBL] [Abstract][Full Text] [Related]
10. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway. Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720 [TBL] [Abstract][Full Text] [Related]
11. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway. Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846 [TBL] [Abstract][Full Text] [Related]
12. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR. Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787 [TBL] [Abstract][Full Text] [Related]
13. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6. Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074 [TBL] [Abstract][Full Text] [Related]
14. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728 [TBL] [Abstract][Full Text] [Related]
15. p-Hydroxylcinnamaldehyde induces the differentiation of oesophageal carcinoma cells via the cAMP-RhoA-MAPK signalling pathway. Ma M; Zhao LM; Yang XX; Shan YN; Cui WX; Chen L; Shan BE Sci Rep; 2016 Aug; 6():31315. PubMed ID: 27501997 [TBL] [Abstract][Full Text] [Related]
16. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells. Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9. Zhang BX; Yu T; Yu Z; Yang XG Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6497-6504. PubMed ID: 31378889 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway. Wang Y; Yu XJ; Zhou W; Chu YX Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3. Wang D; You D; Pan Y; Liu P Thorac Cancer; 2020 Jul; 11(7):1963-1971. PubMed ID: 32449803 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer. Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]